Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 Tampilan
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan